Does the world need to change its vaccine distribution strategy for COVID-19?

Publication Name



During an emergency, there are many activities in a pharmaceutical supply chain (PSC) which are rendered ineffective. This study aims to propose a holistic approach for Big Data Driven Pharmaceuticals Supply Chain (BDDPSC) during medical emergencies. During unprecedented situations, the quality of healthcare services by using traditional supply chain becomes a challenge. The current study aims to generate a model wherein multiple entities will be the part of data entries like hospitals, clinical trials, medical practitioners, and drug manufacturing companies during COVID-19. The study has considered certified medical practitioners as the experts and based their responses for proposing a theoretical framework deploying E-Delphi–Qualitative Data Analysis approach. By critically examining experts’ responses and comments, the study formulated four major themes and ten sub-themes for smooth functioning of BDDPSCs during an emergency. The E-Delphi was conducted in two rounds to reach final consensus and to find a balance for PSC in terms of efficiency and quality. This research is novel wherein big data enabled PSC theoretical model has been formulated using a qualitative approach for handling COVID-19. The proposed framework provides an enriched way to capture data from the important link viz. “health officials” of PSCs.

Open Access Status

This publication is not available as open access



Article Number


Funding Sponsor